Meghan A. Rice

1.4k total citations · 2 hit papers
18 papers, 806 citations indexed

About

Meghan A. Rice is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Meghan A. Rice has authored 18 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Meghan A. Rice's work include Prostate Cancer Treatment and Research (6 papers), Peptidase Inhibition and Analysis (3 papers) and Pluripotent Stem Cells Research (2 papers). Meghan A. Rice is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Peptidase Inhibition and Analysis (3 papers) and Pluripotent Stem Cells Research (2 papers). Meghan A. Rice collaborates with scholars based in United States, France and South Sudan. Meghan A. Rice's co-authors include Tanya Stoyanova, Sanjay V. Malhotra, Merve Aslan, En‐Chi Hsu, Ali Ghoochani, James D. Brooks, Holly M. Nguyen, Eva Corey, Ramasamy Paulmurugan and Sharon J. Pitteri and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Meghan A. Rice

18 papers receiving 800 citations

Hit Papers

Second-Generation Antiandrogens: From Discovery to Standa... 2019 2026 2021 2023 2019 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meghan A. Rice United States 13 435 432 288 162 61 18 806
Ramakumar Tummala United States 14 717 1.6× 378 0.9× 455 1.6× 149 0.9× 69 1.1× 22 1.0k
Daksh Thaper Canada 12 465 1.1× 471 1.1× 207 0.7× 241 1.5× 32 0.5× 21 779
Simeng Wen China 17 559 1.3× 310 0.7× 407 1.4× 224 1.4× 59 1.0× 30 933
Simon J. Baumgart Germany 16 672 1.5× 296 0.7× 191 0.7× 255 1.6× 31 0.5× 27 949
Alan P. Lombard United States 15 392 0.9× 404 0.9× 208 0.7× 138 0.9× 97 1.6× 34 728
Cai Bowen United States 12 573 1.3× 360 0.8× 198 0.7× 247 1.5× 41 0.7× 19 882
Maria Thadani‐Mulero United States 7 307 0.7× 521 1.2× 255 0.9× 203 1.3× 84 1.4× 11 797
Holger H.H. Erb Germany 17 626 1.4× 453 1.0× 393 1.4× 366 2.3× 77 1.3× 58 1.2k
Efrosini Tsouko United States 11 640 1.5× 282 0.7× 520 1.8× 240 1.5× 53 0.9× 14 1.1k
Tisheeka Graham United States 7 429 1.0× 206 0.5× 173 0.6× 340 2.1× 48 0.8× 10 652

Countries citing papers authored by Meghan A. Rice

Since Specialization
Citations

This map shows the geographic impact of Meghan A. Rice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan A. Rice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan A. Rice more than expected).

Fields of papers citing papers by Meghan A. Rice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan A. Rice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan A. Rice. The network helps show where Meghan A. Rice may publish in the future.

Co-authorship network of co-authors of Meghan A. Rice

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan A. Rice. A scholar is included among the top collaborators of Meghan A. Rice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan A. Rice. Meghan A. Rice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shen, Michelle, Fernando Jose Garcia-Marques, Shiqin Liu, et al.. (2024). Identification of a 5-gene signature panel for the prediction of prostate cancer progression. British Journal of Cancer. 131(11). 1748–1761. 1 indexed citations
2.
Gustafson, W. Clay, David Wildes, Meghan A. Rice, et al.. (2022). Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor.. Journal of Clinical Oncology. 40(4_suppl). 591–591. 23 indexed citations
3.
Ghoochani, Ali, En‐Chi Hsu, Merve Aslan, et al.. (2021). Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer. Cancer Research. 81(6). 1583–1594. 215 indexed citations breakdown →
4.
Xie, Jinghang, Meghan A. Rice, Zixin Chen, et al.. (2021). In Vivo Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk Stratification. Cancer Research. 81(9). 2510–2521. 11 indexed citations
5.
Aslan, Merve, En‐Chi Hsu, Fernando Jose Garcia-Marques, et al.. (2021). Oncogene-mediated metabolic gene signature predicts breast cancer outcome. npj Breast Cancer. 7(1). 141–141. 40 indexed citations
6.
Jayaprakash, Priyamvada, Meghan A. Rice, Joseph R. Marszalek, et al.. (2021). 622 Disrupted oxygen supply and tumor hyper- oxygen consumption contribute independently to prostate cancer immune privilege. Regular and Young Investigator Award Abstracts. A652–A652. 1 indexed citations
7.
Liu, Shiqin, Michelle Shen, En‐Chi Hsu, et al.. (2020). Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer. British Journal of Cancer. 124(5). 896–900. 28 indexed citations
8.
Buckup, Mark, Meghan A. Rice, En‐Chi Hsu, et al.. (2020). Plectin is a regulator of prostate cancer growth and metastasis. Oncogene. 40(3). 663–676. 41 indexed citations
9.
Rice, Meghan A., et al.. (2019). Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen Therapies. Molecular Cancer Therapeutics. 18(7). 1230–1242. 41 indexed citations
10.
Zhao, Ning, Chen Hao Lo, Meghan A. Rice, et al.. (2019). Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer. Science Translational Medicine. 11(498). 41 indexed citations
11.
Rice, Meghan A., Sanjay V. Malhotra, & Tanya Stoyanova. (2019). Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer. Frontiers in Oncology. 9. 801–801. 221 indexed citations breakdown →
12.
Going, Catherine C., Dhanir Tailor, Vineet Kumar, et al.. (2018). Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast Cancer. Journal of Proteome Research. 17(10). 3574–3585. 19 indexed citations
13.
Zhao, Ning, Chen Hao Lo, Meghan A. Rice, et al.. (2018). Abstract A063: Preclinical evaluation of an arginine vasopressin receptor 1A (AVPR1A) antagonist in castration-resistant prostate cancer. Cancer Research. 78(16_Supplement). A063–A063. 1 indexed citations
14.
Xie, Jinghang, Meghan A. Rice, Yunfeng Cheng, et al.. (2018). Abstract B068: Methionine aminopeptidase II (MetAP2) activated in situ self-assembly of small-molecule probes for imaging prostate cancer. Cancer Research. 78(16_Supplement). B068–B068. 1 indexed citations
15.
Rice, Meghan A., et al.. (2017). Targeting AR Variant–Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities. Molecular Cancer Research. 15(11). 1469–1480. 17 indexed citations
16.
Rice, Meghan A., Travis J. Yates, Philip Miller, et al.. (2016). The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related. Oncogene. 35(36). 4752–4761. 37 indexed citations
17.
Weaver, Kelly, Marie‐Clotilde Alves‐Guerra, Ke Jin, et al.. (2014). NACK Is an Integral Component of the Notch Transcriptional Activation Complex and Is Critical for Development and Tumorigenesis. Cancer Research. 74(17). 4741–4751. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026